Analysis of IgE binding proteins of mesquite (Prosopis juliflora) pollen and cross-reactivity with predominant tree pollens A Dhyani, N Arora, SN Gaur, VK Jain, S Sridhara, BP Singh Immunobiology 211 (9), 733-740, 2006 | 46 | 2006 |
Cytomegalovirus and Epstein-Barr infections: prevalence and impact on patients with hematological diseases J de Melo Silva, R Pinheiro-Silva, A Dhyani, GS Pontes BioMed research international 2020, 2020 | 39 | 2020 |
ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells A Dhyani, A Duarte, J Machado-Neto, S Saad FEBS Letters 586 (24), 4311–4318, 2012 | 34 | 2012 |
ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth A Dhyani, JA Machado-Neto, P Favaro, STO Saad European journal of cancer 51 (2), 252-259, 2015 | 26 | 2015 |
Immunoglobulin E (IgE)-mediated cross-reactivity between mesquite pollen proteins and lima bean, an edible legume A Dhyani, N Arora, VK Jain, S Sridhara, BP Singh Clinical & Experimental Immunology 149 (3), 517-524, 2007 | 23 | 2007 |
Epidemiological, clinical, and severity characterization of sickle cell disease in a population from the Brazilian Amazon P Cesar, A Dhyani, LA Schwade, P Acordi, CX Albuquerque, R Nina, ... Hematology/Oncology and Stem Cell Therapy 12 (4), 204-210, 2019 | 18 | 2019 |
A clinically relevant major cross‐reactive allergen from mesquite tree pollen A Dhyani, BP Singh, N Arora, VK Jain, S Sridhara European journal of clinical investigation 38 (10), 774-781, 2008 | 17 | 2008 |
Anticancer and immunomodulatory activities of a novel water-soluble derivative of ellipticine R Costa de Oliveira, G Soares Pontes, A Kostyuk, GB Coutinho Camargo, ... Molecules 25 (9), 2130, 2020 | 16 | 2020 |
Impact of Duffy polymorphisms on parasite density in Brazilian Amazonian patients infected by Plasmodium vivax RK Abou-Ali, A Dhyani, AL Terço, DM Toro, KS Gomes, LC Tezza, ... Malaria Journal 18, 1-9, 2019 | 6 | 2019 |
ANKHD1 is an S phase protein required for histone synthesis and DNA repair in multiple myeloma cells A Dhyani, P Favaro, STO Saad Blood Cells, Molecules, and Diseases 84, 102460, 2020 | 4 | 2020 |
Molecular Characterization of Chryseobacterium indologenes with Multidrug Resistance in the Brazilian Amazon Region EA Freitas, WA Ferreira, RAAB Filho, CMC Oliveira, A Dhyani, LM Silva, ... Microbial Drug Resistance 25 (5), 781-786, 2019 | 2 | 2019 |
ANKHD1 Is Essential for Repair of DNA Double-Strand Breaks in Multiple Myeloma A Dhyani, P Favaro, STO Saad Blood 126 (23), 1762, 2015 | 1 | 2015 |
Pharmacological assessment of the antineoplastic and immunomodulatory properties of a new spiroindolone derivative (7’, 8’-Dimethoxy-1’, 3’-dimethyl-1, 2, 3’, 4 … CE de Castro Alves, SL Bogza, N Bohdan, AB Rozhenko, ... Investigational New Drugs 41 (5), 629-637, 2023 | | 2023 |
ANKHD1 Is Required for S Phase Progression and Histone Gene Transcription in Multiple Myeloma A Dhyani, P Favro, STO Saad Blood 124 (21), 2002, 2014 | | 2014 |
ANKHD1 Silencing Reduces In Vitro Clonogenicity and In Vivo Tumorogenicity Of Multiple Myeloma Cells A Dhyani, JA Machado-Neto, P Favaro, STO Saad Blood 122 (21), 3168, 2013 | | 2013 |
ANKHD1 Silencing Induces S-Phase Arrest and Modulates Cell Cycle Gene Expression in Human Myeloma Cells A Dhyani, ASS Duarte, P Favaro, STO Saad Blood 118 (21), 1828, 2011 | | 2011 |